Article

Comparing multifocal, accommodating IOLs

Author(s):

Outcomes for three presbyopia-correcting IOLs-one accommodating and two multifocals-were similar, said Robert Edward Ang, MD.

New Orleans-Outcomes for three presbyopia-correcting IOLs-one accommodating and two multifocals-were similar, said Robert Edward Ang, MD.

“In terms of binocular high-contrast, uncorrected distance visual acuity, there was no statistical difference in distance vision among the three lenses,” said Dr. Ang, of Makati, Philippines.

Refractive outcomes were also stable in all lenses, as long as the capsule was taken care of, he added. 

At 1 year, his prospective, randomized study compared 71 patients with a mean age of 65 years implanted bilaterally either with an accommodating IOL (Crystalens, Bausch + Lomb) or one of two multifocal IOLs (ReSTOR, Alcon Laboratories; or Tecnis Multifocal, Abbott Medical Optics).

For uncorrected intermediate visual acuity, his study showed the Crystalens outcomes were superior. For uncorrected near visual acuity, his study recorded better results with the multifocals, especially the ReSTOR.

In terms of distance-corrected intermediate visual acuity, patients in the study had the best outcomes with Crystalens. With distance-corrected near visual acuity, the multifocals showed better outcomes. 

Dr. Ang also tracked reports of halos and starbursting, both of which were less with Crystalens, but YAG rates were higher with this IOL. The lowest YAG rates were with the Tecnis.

Results for binocular mean visual acuities in the 3 groups: Crystalens, ReSTOR, and Tecnis, respectively.

  • Uncorrected distance visual acuity:                     20/20, 20/20, 20/21

  • Uncorrected intermediate visual acuity:               20/20, 20/24, 20/26

  • Uncorrected near visual acuity visual acuity:       20/25, 20/20, 20/23

  • Distance-corrected intermediate visual acuity:     20/20, 20/24, 20/25

  • Distance-corrected near visual acuity:                 20/26, 20/19, 20/21

For more articles in this issue of Ophthalmology Times Conference Brief click here.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.